Immunic Inc (NASDAQ: IMUX) on Monday, soared 12.90% from the previous trading day, before settling in for the closing price of $1.24. Within the past 52 weeks, IMUX’s price has moved between $0.97 and $2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 54.30%. With a float of $87.36 million, this company’s outstanding shares have now reached $90.08 million.
The firm has a total of 77 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immunic Inc is 3.02%, while institutional ownership is 62.53%. The most recent insider transaction that took place on Nov 12 ’24, was worth 100,369. In this transaction Director of this company bought 87,300 shares at a rate of $1.15, taking the stock ownership to the 87,300 shares.
Immunic Inc (IMUX) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.48 earnings per share (EPS) for the period topping the consensus outlook (set at -0.54) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.50% during the next five years compared to 31.12% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Immunic Inc (IMUX) is currently performing well based on its current performance indicators. A quick ratio of 2.71 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
Analysing the last 5-days average volume posted by the [Immunic Inc, IMUX], we can find that recorded value of 0.96 million was better than the volume posted last year of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 80.15%. Additionally, its Average True Range was 0.10.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 34.86%, which indicates a significant decrease from 95.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.51% in the past 14 days, which was higher than the 75.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3489, while its 200-day Moving Average is $1.3342. Now, the first resistance to watch is $1.4633. This is followed by the second major resistance level at $1.5267. The third major resistance level sits at $1.6333. If the price goes on to break the first support level at $1.2933, it is likely to go to the next support level at $1.1867. Now, if the price goes above the second support level, the third support stands at $1.1233.
Immunic Inc (NASDAQ: IMUX) Key Stats
Market capitalization of the company is 126.11 million based on 90,079K outstanding shares. Right now, sales total 0 K and income totals -93,610 K. The company made 0 K in profit during its latest quarter, and -24,370 K in sales during its previous quarter.
